The prevention of heart failure - a new agenda

Article Abstract:

Three different research studies evaluated the use of angiotensin-converting-enzyme (ACE) inhibitors to prevent heart failure in patients with cardiac dysfunction. Patients who have had a heart attack often have damage to their heart that causes progressive cardiac dysfunction. One study found that treatment with enalapril before the onset of heart failure did not increase survival significantly in patients with left ventricular dysfunction. In patients with left ventricular dysfunction, the heart is incapable of pumping enough blood to the rest of the body. Treatment with enalapril did increase survival by 8%, which may hold some promise for the future. Another study found that early treatment with captopril in heart attack patients with some left ventricular dysfunction may increase survival. The third study found that starting early treatment of heart attack patients with enalapril did not increase survival.

Congestive heart failure

---

Prevention of end-stage renal disease due to type 2 diabetes

Article Abstract:

ACE inhibitors and angiotensin II-receptor blockers appear to slow the progression of kidney disease in people with type 2 diabetes and should be used more often. The number of people with type 2 diabetes is increasing, and diabetes is a major risk factor for end-stage kidney disease.

Type 2 diabetes, Diabetic nephropathies, Complications, Angiotensin II receptor blockers

---

Similar abstracts:

• Abstracts: Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease
• Abstracts: The role of the nurses specialist in osteoporosis. Space to do their own thing. Don't lose heart
• Abstracts: The enigma of low birth weight and race. Racial disparity in rates of surgery for lung cancer
• Abstracts: Improving the management of children's pain in A&E. Pain from sickle-cell crisis. An audit of pain management in acute sickle cell crisis
• Abstracts: The private practice of nursing: the gift of entrereneurialism. After a merger: the dilemma of the best leadership approach for nursing

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.